Table 1 Patients’ characteristics for each hospital
| Â | Site 1 n = 3 | Site 2 n = 1 | Site 3 n = 2 | Site 4 n = 14 | Site 5 n = 2 | Site 6 n = 2 | Site 7 n = 1 | Site 8 n = 1 | Site 9 n = 14 | All n = 40 |
|---|---|---|---|---|---|---|---|---|---|---|
Age (years) | 61.3 ± 16.1 | 71.0 ± 0.0 | 63.0 ± 0.0 | 60.0±10.1 | 73.5 ± 4.5 | 57.0 ± 9.0 | 73.0 ± 0.0 | 70.0 ± 0.0 | 59.5 ± 12.6 | 61.5 ± 11.6 |
Sex (male: female) | 0: 3 | 0: 1 | 0: 2 | 2: 12 | 0: 2 | 0: 2 | 0: 1 | 0: 1 | 2: 12 | 4: 36 |
RA duration (years) | 10.7 ± 9.5 | N/A | 14.0 ± 11.0 | 6.5 ± 4.6 | 20.0 ± 19.0 | 9.5 ± 1.5 | 13.0 ± 0.0 | 9.0 ± 0.0 | 15.1 ± 10.0 | 11.4 ± 9.7 |
MTX | 3 (100%) | 1 (100%) | 2 (100%) | 12 (86%) | 1 (50%) | 1 (50%) | 1 (100%) | 1 (100%) | 11 (79%) | 33 (83%) |
Glucocorticoids | 1 (33%) | 1 (100%) | 1 (50%) | 13 (93%) | 2 (100%) | 2 (100%) | 1 (100%) | 0 (0%) | 5 (36%) | 26 (66%) |
bDMARDs | 2 (67%) | 0 (0%) | 1 (50%) | 6 (43%) | 0 (0%) | 0 (0%) | 1 (100%) | 1 (100%) | 9 (64%) | 20 (50%) |